FDA Approves Sleeping Sickness Therapy
The federal agency gives nod for fexinidazole as the first all-oral treatment for the parasitic illness.
The COVID-19 Pandemic and Resumption of PrEP Therapy
Small survey from gay and bisexual men (GBM) inquired about their experiences during COVID-19 restrictions, and feedback on PrEP.
CDC Confirms Case of Human Monkeypox in US Resident
The case was identified in an individual who had recently returned from a trip to Nigeria.
Impact of Home-Based Testing on Uptake and Knowledge of HIV Status
No significant difference was observed across the 3 study groups.
COVID-19 Humoral and T-Cell Immune Responses Among People Living With HIV
A positive relationship may exist between infection severity and adaptive immunity.
Outreach for PrEP Counseling Shows Ability to Reach Underserved Communities
In Brazil, a concerted effort of recruiting adolescents was made to go out and talk with them about PrEP.
Do Adverse Childhood Experiences Impact PrEP Uptake in Young Adulthood?
Rates of testing for HIV, as well as PrEP uptake, remain suboptimal in MSM of color.
Mortality of People Entering HIV Care Drops, Nearing That of General Population
US residents with HIV have higher rates of mortality than their peers without infection, but the gap is narrowing, a recent study showed.
Offering Market Incentives to Address Antimicrobial Resistance
The Pasteur Act in Congress is designed to incentivize pharmaceutical companies to develop new antibiotics.
Understanding PrEP Preferences in a Select Population
Investigators surveyed men who have sex with men (MSM) about long-acting injectable pre-exposure prophylaxis (PrEP) including attitudes towards potentially taking it and barriers to usage.
HIV Testing, Positive Results Dropped in the US During COVID-19
The pandemic's effect on in-person care prioritization may have indirectly influenced the rate of screening opportunities in at-risk persons.
Cabotegravir Plus Rilpivirine Well-Received by HIV Care Staff, Patients at 12 Months
New findings from CUSTOMIZE suggest the once-monthly injection therapy was feasibly implemented and generally favored to once-daily tablets.
Study: Homeless Persons with HIV Prefer Flexible Care Models, No Telehealth
Perspective gained from persons treated a real-world clinic may help better inform strategies to treat an HIV population that often struggles with viral suppression and consistent care.
COVID-19 Severe Risks Not Significant in People with HIV
A new study from IAS 2021 suggests persons with HIV hospitalized for COVID-19 do not face worse mortality nor major cardiovascular event risk.
Those at High Risk Know about PrEP but Use Remains low
Results from the study highlight the importance of PrEP education in clinical settings.
FDA Approves Pneumococcal 15-Valent Conjugate Vaccine for US Adults
The prophylaxis showed non-inferiority across shared serotypes with an available 13-valent vaccine in its indication-supporting data.
FDA Grants Priority Review to Pfizer-BioNTech COVID-19 Vaccine
The designation moves the companies' PDUFA date up to January 2022, when BNT162b2 may become the first regulated COVID-19 vaccine.
Education Remains Significant to Public Understanding About HIV, Prevention
As younger generations come of age, there is a continuous need to inform them about HIV risks, offer insights about prevention strategies, and understand the challenges for people living with HIV (PLWH).
Single Dose of Sputnik V Vaccine Triggers Strong Response
94% of the participants developed IgG antibodies against the virus 3 weeks after administration.
Blood Tests May Help Monitor SARS-CoV-2 Infection
Truncated ACE2 levels served to discriminate patients infected with SARS-CoV-2 and influenza A.
Antibiotics in Early Childhood Have Small Effect on BMI Milestones
Exposure to antibiotics in childhood was found to have small effect on trajectory of body mass index milestones.
Complications in Hospitalized COVID-19 Patients More Common, Affect Younger Population
A large study finds 1 out of 2 patients develop at least one during their hospital stay.
Understanding HPV Vaccine Hesitancy
The HPV vaccine is incredibly important in preventing certain cancers and a new study sought to address the safety concerns for vaccine refusal in a national immunization survey for teenagers.
Janssen COVID-19 Vaccine Elicits Immune Response for At Least 8 Months
The Johnson & Johnson vaccine showed neutralizing antibody responses against variants of concern.
PrEP Use Disparities Worsening Between Early and Late Adopting States
PrEP use is estimated to prevent >90% of infections in men who have sex with men and 70% of infections in people who inject drugs.
Ohio COVID Vaccine Lottery Did Not Boost Vaccination Rates, Evidence Shows
Before other states adopt randomly-selected payouts for COVID-19 vaccine administration, further research is needed into these lotteries’ effects on potential increases in vaccination rates.
Molnupiravir Shows Promise for Treatment of Moderate COVID-19 in Phase 2/3 Trial
The MOVe-OUT study will continue to the phase 3 portion and evaluate 800 mg of the therapy administered twice daily.
Efficacy Information May Help Convert COVID-19 Vaccine Doubters
With vaccine uptake slowing, any information that can help is needed to increase administration.
Those With Chronic Lung Disease Have Poorer COVID-19 Outcomes, More Severe Symptoms
Genetic changes enable SARS-CoV-2 to enter the body, replicate and trigger out-of-control immune responses.
Antimicrobial Resistance Presents a Significant Threat
A recent press briefing by the Infectious Diseases Society of America (IDSA) addressed the need to have new antibiotics in the pipeline to answer the rising challenge of drug resistance.
